Minich Mac Gregor Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Minich Mac Gregor Wealth Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 09, 2023	BUY	$68.48 - $81.09 $73,547 - $87,090	1,074 New	1,074 $0
Q2 2020 Aug 05, 2020	SELL	$54.82 - $64.09 $323,876 - $378,643	-5,908 Closed	0 $0
Q1 2020 Apr 21, 2020	BUY	$46.4 - $67.43 $274,131 - $398,376	5,908 New	5,908 $351,000
Q4 2018 Jan 17, 2019	SELL	$48.76 - $63.23 $46,858 - $60,764	-961 Closed	0 $0
Q3 2018 Oct 17, 2018	BUY	$55.19 - $62.25 $4,525 - $5,104	82 Added 9.33%	961 $59,000
Q2 2018 Jul 13, 2018	SELL	$50.53 - $62.98 $12,228 - $15,241	-242 Reduced 21.59%	879 $48,000
Q1 2018 Jul 03, 2018	SELL	$59.92 - $68.98 $50,692 - $58,357	-846 Reduced 43.01%	1,121 $70,000
Q3 2017 Jul 03, 2018	BUY	$55.23 - $63.74 $5,081 - $5,864	92 Added 4.91%	1,967 $125,000
Q1 2017 Jun 28, 2018	SELL	N/A	-562 Reduced 23.06%	1,875 $101,000
Q4 2016 Jun 28, 2018	BUY	N/A	57 Added 2.39%	2,437 $142,000
Q3 2016 Jun 28, 2018	BUY	N/A	358 Added 17.71%	2,380 $128,000
Q2 2016 Jun 28, 2018	SELL	N/A	-404 Reduced 16.65%	2,022 $148,000
Q1 2016 Jun 28, 2018	SELL	N/A	-47 Reduced 1.9%	2,426 $154,000
Q4 2015 Jun 27, 2018	BUY	N/A	2,473	2,473 $159,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Minich Mac Gregor Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Minich Mac Gregor Wealth Management, LLC with notifications on news.